Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children
Main Authors: | Muwanguzi, Julian, Henriques, Gisela, Sawa, Patrick, Bousema, Teun, Sutherland, Colin J., Beshir, Khalid B. |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722670/ |
Similar Items
-
Residual Plasmodium falciparum Parasitemia in Kenyan Children After Artemisinin-Combination Therapy Is Associated With Increased Transmission to Mosquitoes and Parasite Recurrence
by: Beshir, Khalid B., et al.
Published: (2013) -
Directional Selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu Loci of Plasmodium falciparum in Kenyan Children Treated With ACT
by: Henriques, Gisela, et al.
Published: (2014) -
Genetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum Parasites
by: Chebon, Lorna J., et al.
Published: (2016) -
Recognition of Plasmodium falciparum gametocyte surface antigens by plasma antibodies in asymptomatic Ghanaian school children
by: Dinko, Bismarck, et al.
Published: (2012) -
Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda
by: Chang, Hsiao-Han, et al.
Published: (2016)